We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$12B
AUM Growth
-$882M
Cap. Flow
-$307M
Cap. Flow %
-2.56%
Top 10 Hldgs %
23.8%
Holding
2,895
New
41
Increased
683
Reduced
1,007
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 13.65%
3 Financials 12.21%
4 Consumer Discretionary 10.98%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
1576
Amylyx Pharmaceuticals
AMLX
$2.6B
$548K ﹤0.01%
19,461
+12,676
+187% +$316K
ANDE icon
1577
Andersons Inc
ANDE
$2.21B
$546K ﹤0.01%
17,581
CSR
1578
Centerspace
CSR
$925M
$544K ﹤0.01%
8,088
+271
+3% +$21.5K
CASH icon
1579
Pathward Financial
CASH
$1.78B
$544K ﹤0.01%
16,505
ALHC icon
1580
Alignment Healthcare
ALHC
$2.8B
$544K ﹤0.01%
45,938
UTZ icon
1581
Utz Brands
UTZ
$1.25B
$544K ﹤0.01%
36,012
DIN icon
1582
Dine Brands
DIN
$462M
$542K ﹤0.01%
8,526
HLMN icon
1583
Hillman Solutions
HLMN
$1.73B
$541K ﹤0.01%
71,761
ZNTL icon
1584
Zentalis Pharmaceuticals
ZNTL
$297M
$540K ﹤0.01%
24,936
+5,271
+27% +$144K
LADR
1585
Ladder Capital
LADR
$1.25B
$539K ﹤0.01%
60,111
LOB icon
1586
Live Oak Bancshares
LOB
$1.98B
$538K ﹤0.01%
17,593
CCK icon
1587
Crown Holdings
CCK
$13.1B
$538K ﹤0.01%
6,639
-100
-1% -$9.32K
HEI.A icon
1588
HEICO Corp Class A
HEI.A
$38B
$538K ﹤0.01%
4,691
+1
+0% +$120
ENTA icon
1589
Enanta Pharmaceuticals
ENTA
$393M
$536K ﹤0.01%
10,340
-619
-6% -$36.2K
AUPH icon
1590
Aurinia Pharmaceuticals
AUPH
$2.06B
$535K ﹤0.01%
71,201
CRNX icon
1591
Crinetics Pharmaceuticals
CRNX
$8.96B
$535K ﹤0.01%
27,255
+1,838
+7% +$37.5K
FSLY icon
1592
Fastly Inc
FSLY
$4.78B
$532K ﹤0.01%
58,108
BGC icon
1593
BGC Group
BGC
$5.12B
$532K ﹤0.01%
169,488
+20,583
+14% +$79.7K
AKRO
1594
DELISTED
Akero Therapeutics
AKRO
$530K ﹤0.01%
15,580
TNC icon
1595
Tennant Co
TNC
$1.18B
$530K ﹤0.01%
9,364
VRE
1596
DELISTED
Veris Residential
VRE
$529K ﹤0.01%
46,558
+2,023
+5% +$27.2K
IMGN
1597
DELISTED
Immunogen Inc
IMGN
$528K ﹤0.01%
110,444
+9,667
+10% +$51K
SWTX
1598
DELISTED
SpringWorks Therapeutics
SWTX
$526K ﹤0.01%
18,422
+1,454
+9% +$41.7K
LBAI
1599
DELISTED
Lakeland Bancorp Inc
LBAI
$524K ﹤0.01%
32,726
DDD icon
1600
3D Systems Corp
DDD
$603M
$524K ﹤0.01%
65,646

Similar funds

MetLife Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, MetLife Investment Management held 2,895 positions worth $12B, down 6.8% from $12.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. MetLife Investment Management opened 41 new positions and exited 96, leaving the 2,895-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q3 2022 buy was Aspen Technology Inc: 19,662 shares worth $4.68M.
  • MetLife Investment Management added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $24.5M increase.
  • MetLife Investment Management's biggest Q3 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $138M.
  • MetLife Investment Management fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.77M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12B portfolio in Q3 2022.
  • MetLife Investment Management opened 41 new positions and closed 96 in Q3 2022.
  • MetLife Investment Management's portfolio value fell 6.8% quarter-over-quarter to $12B.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.